GLP1R and type 2 diabetes mellitus: Secondary objectives were to estimate the prevalence of high CVD risk in adults with T2D without established CVD (full results to be published elsewhere) and to further characterize the study sample regarding demographics, clinical parameters, CV medication and GLA usage, with particular reference to GLAs (GLP-1 RAs and SGLT2is) with demonstrated CV benefit.